Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Cardiol Therapeutics Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 27 | 32 | +5 |
| Shares | 5.72M | 6.77M | +1.05M (+18.4%) |
| Value | $6.25M | $3.64M | −$2.61M (−41.8%) |
New holders (10)
Institutions that held Cardiol Therapeutics Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tejara Capital Ltd | 440,626 | $224.7K | 0.13% |
| Goldman Sachs Group Inc | 101,500 | $51.8K | 0.00% |
| Jane Street Group, LLC | 63,073 | $32.1K | 0.00% |
| Two Sigma Securities, LLC | 33,564 | $17.1K | 0.00% |
| StoneX Group Inc. | 10,586 | $5.40K | 0.00% |
| Advisory Services Network, LLC | 3,458 | $1.76K | 0.00% |
| Piscataqua Savings Bank | 3,000 | $1.53K | 0.00% |
| South State Corp. | 1,000 | $510 | 0.00% |
| NewSquare Capital LLC | 700 | $357 | 0.00% |
| Group One Trading, L.P. | 1 | $1 | 0.00% |
Sold out (5)
Institutions that held Cardiol Therapeutics Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Citadel Advisors LLC | 46,204 | $48.0K |
| Millennium Management LLC | 34,543 | $36.0K |
| Susquehanna International Group, LLP | 19,226 | $20.0K |
| We Are One Seven, LLC | 10,000 | $10.0K |
| Bank of America Corp | 1,399 | $1.00K |